Crossmark

Incidence and clinical importance of BCR-ABL1 mutations in Iranian patients with chronic myeloid leukemia on imatinib

Crossref DOI link: https://doi.org/10.1038/jhg.2015.11

Published Online: 2015-03-05

Published Print: 2015-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Rostami, Golale

Hamid, Mohammad

Yaran, Majid

Khani, Mohsen

Karimipoor, Morteza
License Information

Text and Data Mining valid from 2015-03-05
More Information

Article History

Received: 2 September 2014

Revised: 3 December 2014

Accepted: 13 January 2015

First Online: 5 March 2015

Competing interests

: The authors declare no conflict of interest.